The Mission is what drives us.

Our Mission.

 

The Mountain States Hemophilia Network (MSHN) provides specialty medical care to people with blood or clotting disorders through our regional hemophilia treatment center (HTC) network.The MSHN is comprisedof federally-supportedHTCs located in Albuquerque, Anchorage, Boise, Denver, Phoenix, Portland, Salt Lake City, Seattle,Spokane and Tucson withseveral partner centers delivering care across the lifespan.MSHN includes seven of the 10 largest states in geographic size in the United States and covers over 1.5 million square miles. This large geographic area brings unique challenges but also allows for regional partnerships and collaborations with patients, families, local providersand care teamswho are dedicated to improving health and wellness in the bleeding and clotting disorders communities.

MSHN stands for excellence in collaboration and innovation. Our mission is to enable our member centers to improve the health and well-being for all people with bleeding and clotting disorders by:

  • Advancing the bleeding and clotting disorders field through joint research, education, and advocacy between our member centers.
  • Providing the expertise necessary to enable our member centers to provide the care necessary to achieve the best possible outcomes for all those affected by bleeding and clotting disorders.
  • Fostering a culture of collaboration, respect, diversity, and inclusion.

Our Goals.

  • Provide and facilitate access to integrated, comprehensive care for all persons with bleeding or clotting disorders
  • Develop, enhance, and sustain collaboration and communication with patients with bleeding disorders and their families, as well as intraregional and interregional partners and stakeholders
  • Support a system to monitor clinical outcomes and evaluate models of care by facilitating and maintaining strategies forregional quality improvement
  • Foster and maintain sustainability in the provision of services to persons affected by bleeding and clotting disorders
  • Advocate in collaboration with local, state, regional and national partners on behalf of populations servedto ensure access to specialized integrated care and access to insurance coverage.
  • Advance hemostasis care through research, advocacy and education amongst our HTCs and through national and international ventures.